ReLapsNCT07178925
Follow-up Cohort of Patients With Antiphospholipid Syndrome
StatusRecruiting
PhaseNot specified
SponsorUniversity Hospital, Rouen
Primary completion (estimated)
At risk: Primary completion moved 12 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Primary completion pushed from Oct 16, 2026 to Oct 16, 2027
- Eligibility criteria expanded, about 4 words
- Study completion pushed from Oct 16, 2031 to Oct 16, 2032
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Thrombotic recurrence rate
Timeframe: Patients will be followed up in consultation every 3 months, 6 months to 1 year, for 5 years, depending on the situation. Follow-ups will not be modified compared to the usual management of the disease.
Secondary (4)
Complication rate
Risk factors associated
Mortality rates
Morbidity rates
Arms and interventions
Other: Study of Antiphospholipid Syndrome responding to the Sydney classification of 2006
Sites
1 site in 1 country
- University hospital of RouenRouen, France